Fig. 1: Schema of the SNBNMF model from Lyu et al. 2020
We are interested in the development of approaches that support the molecular characterisation of patient cohorts. With extensive experience in the analysis of diverse types molecular data, the focus lies within integrative approaches, which can holistically harness additional insights into disease mechanisms.
Cancer & Clinical Applications
The group is also involved in the analysis of cohort level data of cancer patients. A particular interest here is to apply our developments to enable new views on existing data that have the potential to make real-world impact by being translated into clinical applications.